Apps

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

IJR News — today's news from every side

LYTENAVA Receives FDA Approval for Wet AMD — Jul 24, 2026Outlook Therapeutics has won FDA approval for LYTENAVA (bevacizumab-vikg), making it the first and only ophthalmic bevacizumab formulation approved for treating wet AMD in the United States and a potential new standard of care developed specifically for the eye. The approval follows a lengthy regulatory history and positions LYTENAVA with anticipated market exclusivity under the BPCIA while signaling a major milestone for retina care.